Results of medical management and XXXX -augmented excisional bleb revision for encapsulated filtering @entity4530 .

@entity1 @entity4530 @entity1138 @entity1139 @entity230
BACKGROUND AND OBJECTIVE: To assess the outcome of medical management and @entity1138 ( @entity1139 )-augmented excisional bleb revision (EBR) for encapsulated filtering @entity4530 . @entity1 AND METHODS: The author conducted a retrospective study of 503 @entity1 who had undergone trabeculectomy performed over a 5 year period, followed up for at least one year, in order to identify the encapsulated filtering @entity4530 . @entity1138 -augmented (0.4mg/ml for 3 minutes) EBR was performed in cases of failed medical therapy for managing encapsulated @entity4530 consisting of antiglaucoma medications, topical @entity230 , and digital compression. RESULTS: An encapsulated bleb developed in 18 eyes (3.6%) of 503 @entity1 . Identification of bleb encapsulation occurred at a mean follow-up time of 24.2 +/- 10.4 days after surgery. The mean intraocular pressure (IOP) at that point was 30.4 +/- 11.7 mmHg in the affected eyes. Fifteen (83.3%) of 18 eyes responded to conservative management and 3 eyes (16.7%) required @entity1139 augmented EBR. The mean IOP reduced from 30.4 +/- 11.7 mmHg to 14.2 +/- 4.2 mmHg after a mean follow-up of 37.6 +/- 11.4 months in the conservative management group, while it reduced from 37.3 +/- 23.4 mmHg to 12.0 +/- 4.4 mmHg after a mean follow-up of 42 +/- 6 months in the surgically treated group. None of the surgically treated eyes developed @entity1139 -related complications. CONCLUSION: Conservative management is very effective in the treatment of encapsulated filtering @entity4530 . The intraoperative use of @entity1139 is a safe and effective adjunct in EBR in cases where conservative management has failed.
